CYP 10.0% 27.5¢ cynata therapeutics limited

2020 - A Year Full Of Potentials, page-216

  1. 12,570 Posts.
    lightbulb Created with Sketch. 3397
    I'm an investor in both camp

    I'll give this a go...

    Park GVHD aside for a moment & look at the two companies:

    MSB & CYP are chalk & cheese.
    You would invest in MSB for a late stage, product driven & capital intesive MSC company.

    You would invest in CYP for a manufacturing tech platform company in iPSC, early stage, partnerhip focussed (light on capital, partners to run trials) company.

    They are in a different stage of company lifecycle & their risks profile, MC & growth projections are vastly different

    So back to GVHD:
    MSB is to deliver a US product for kids
    CYP is proving their manufacturing platform, via Fuji, for aldults
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.